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Abstract
        We report a case of a 63-year-old man, with a previous history 
of hypertension and glucose intolerance associated troncular obe-
sity that was emergently admitted to our Institution for evaluation 
of a severe, constant posterior chest pain which radiated anteriorly 
and dyspnoea with a suspected diagnosis of acute aortic dissection. 
A CT scan of thorax and abdomen demonstrated a dissection start-
ing just below left succlavian artery and extending downward to the 
left renal artery, involving the celiac tripod and superior mesenteric 
artery. The dissection was classified as Stanford B, De Bakey III. 
Moreover, CT scan of abdomen revealed incidentally a left adre-
nal tumor of 25 mm of diameter. An emergent prosthetic graft was 
placed just below the origin of the left succlavian artery up-to the 
diaphragmatic hiatus. Furthermore, a diagnostic evaluation of the 
mass revealed an increase of cortisol production, and a diagnosis 
of Cushing’s syndrome was done and the patient underwent an ad-
renalectomy via laparotomic approach. We report an association of 
acute aortic dissection of acute aortic dissection type B associated 
to Cushing’s syndrome.
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Introduction
Cushing’s syndrome (CS) occurs in about 2 per mil-
lion of the general population [1]. CS refers to the signs and 
symptoms caused by an excessive action of glucocorticoids 
[2, 3]. Endogenous CS results from chronic exposure to ex-
cess glucocorticoids produced by the adrenal gland. It may 
be caused by excess ACTH production (80-85%) usually due 
to a pituitary adenoma. In this form of the disease, a female 
to male ratio of  8 to 1 is observed, with an average age rang-
ing from 20 to 40 years among affected women [4].
 Less frequently it is caused by extrapituitary tumour 
(ectopic ACTH syndrome) or, very rarely, by tumour secret-
ing CRH. Furthermore CS can also be ACTH independent 
(15-20%) when it is due to excess secretion of cortisol by 
unilateral adrenocortical tumours, either benign or malig-
nant, or as consequence of bilateral adrenal hyperplasia, es-
pecially in cyclic CS.
 CS is frequently associated with cardiovascular risks 
due to hypercortisolism, leading to cardiovascular complica-
tions, including myocardial infarction, congestive heart fail-
ure and stroke account for high proportion of morbidity and 
mortality in untreated patients [5, 6].
 Although CS has been known as a risk factor for aorta 
dissection, the association of these two entities is extremely 
rare [7, 8]. We report a case of an acute aorta dissection in a 
patient with CS caused by adrenocortical adenoma.
Case Report
 A 63-year-old man with history of hypertension and glu-
cose intolerance since age 59 years was emergently admitted 
to our Institution from a peripheral Hospital for evaluation 
of a severe, constant posterior chest pain, radiating forward, 
and dyspnoea with a suspected diagnosis of acute aortic dis-
section. 
 On physical examination the patient was not shocked, 
his pulse was 87 beats/min, blood pressure 150/105 mmHg. 
He had truncal obesity, a “moon face” and proximal muscle 
weakness. An electrocardiogram showed left ventricular 
hypertrophy. His laboratory work-up revealed anaemia (Hb 
10.7 g/dl), hypokaliemia (3.4 mEq/L), metabolic alkalosis 
(HCO
3
- 35 mmol/L) and hyperglycaemia (170 mg/dl). A CT 
scan of thorax and abdomen demonstrated a dissection start-
ing just below left succlavian artery and extending down-
ward to the left renal artery, involving the celiac tripod and 
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superior mesenteric artery (Fig 1a). The dissection was clas-
sified as Stanford B, De Bakey III. Moreover CT scan of 
abdomen revealed incidentally a left adrenal tumour of 25 
mm of diameter.
 The patient was pharmacologically treated and was felt 
at risk for impending aortic rupture. Therefore, an emergent 
endograft positioning was planned. Our goal was to exclude 
the damaged segment of the aorta and to obliterate the entry 
of blood into the false lumen (both at the initial intimal tear 
and at the secondary tears along the vessel). Through an in-
guinal incision, the right common, superficial and profunda 
femoral artery were dissected free.  A prosthetic graft (Val-
iant, Medtronic, Sunnyvale, CA, USA 42 mm x 198 mm) 
was placed just below the origin of the left succlavian artery 
up to the diaphragmatic hiatus. A postoperative control CT 
scan demonstrated the correct graft positioning, not endole-
aks and the closure of all secondary tears (Fig. 1b).
 This patient was evaluated for hypercortisolism and 
the plasma cortisol was increased to 33.9 µg/dl (vn, value 
of normal, 5.6-23 µg/dl) without circadian rhythm and not 
suppressed by the administration of 1 mg of dexamethasone 
(overnight text: 9.8 µg/dl; vn <1.8 µg/dl ). The plasma ad-
renocorticotropic hormone (ACTH) was less than 10 pg/
ml (vn 12-60 pg/ml) and 24h urinary free cortisol excretion 
(UFC) was elevated 465.6  µg/24 h (vn 26-135 µg/24h ).
 A MRI of abdomen was performed to have a more ac-
curate evaluation of the adrenal mass, it was of 2 cm of di-
ameter, well capsulated, hyperintense in T1 sequences with 
a normal reduction of signal in T2 weighted sequences (Fig 
1c).   
 A diagnosis of CS was made on basis of the endocri-
nological tests and for the presence of left adrenocortical 
lesion. Via laparotomic approach, a left adrenalectomy was 
performed during intravenous replacement of hydrocorti-
sone, ACE-inhibitor, aspirin and insulin therapy.
 Six months after adrenalectomy, blood pressure was 
controlled (135/75 mmHg) with anti-hypertensive therapy, 
laboratory analysis revealed glycaemia 102 mg/dl, glycated 
haemoglobin (HbA1c) 5.7%, potassium 4.26 mEq/l, sodium 
139.7 mEq/L, plasma creatinine 1.05 g/dl, a.m. plasma corti-
sol  9.7 µg/dl, plasma ACTH 28 pg/ml and UFC 45 µg/24h.
 
Discussion
 Primary adrenal hypersecretion of cortisol, mainly from 
unilateral tumours and more rarely from bilateral adrenal 
hyperplasia, is responsible for approximately 15-20% of en-
dogenous CS cases. Among the unilateral tumours, adeno-
mas are found in 60% of cases and carcinomas in the remain-
ing 40%. Approximately 10% of primary adrenal CS is due 
to primary bilateral adrenocortical hyperplasia.
 CS is frequently associated with cardiovascular risks 
(through hypercortisolism), leading to cardiovascular dis-
eases as the mayor cause of death [2]. In particular, the CS is 
associated with hypertension, impaired glucose metabolism 
and hyperlipemia, which represent the crucial cardiovascular 
factors for the atherosclerosis [9, 10]. 
 Studies has shown that unexpected endogenous hyper-
cortisolism occurs in 0.5-1% of patients with hypertension, 
2-3% with poorly controlled diabetes, 6-9% with incidental 
adrenal mass and 11% with osteoporosis and vertebral frac-
Figure 1. (a) A CT scan of thorax and abdomen demonstrated a 
dissection starting just below left succlavian artery and extending 
downward to the left renal artery, involving the celiac tripod and 
superior mesenteric artery. (b) A postoperative control CT scan 
demonstrated the correct graft positioning, not endoleaks and the 
closure of all secondary tears. (c) A MRI of abdomen showing a 
left adrenal lesion of 2 cm of diameter.
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tures [11].
  Although CS has been known as a risk factor for aorta 
dissection, the association of these two entities is not com-
mon. In our case, at the time of the diagnosis of a Stanford 
type B aortic dissection, we revealed a CS due to adrenocor-
tical adenoma. To our knowledge, only two case of dissect-
ing aortic aneurysm simultaneously with CS has been found 
in the English literature [7, 8].
 In 1935, Lawrence and Zimmerman [7] described a 
44-year-old man who presented with the clinical features of 
CS of pituitary basophilism and died as the result of a rup-
tured dissecting aortic aneurysm. In 2004 Takagi et al [8] 
reported a 55-year-old man who presented CS due to adre-
nocortical adenoma and a saccular nondissecting true aneu-
rysm of the distal aortic arch with a mural thrombus and a 
Stanford type B aortic dissection. This patient simultaneous-
ly was operated by left adrenalectomy through laparotomy 
and graft replacement of the distal aortic arch and the proxi-
mal descending thoracic aorta under partial cardiopulmonary 
bypass through a left thoracotomy.
 In our patient, a prosthetic graft (Valiant, Medtronic, 
Sunnyvale, CA, USA 42 mm x 198 mm) was placed firstly 
just below the origin of the left succlavian artery up to the 
diaphragmatic hiatus, and later a left adrenalectomy was per-
formed via laparotomic approach.
 The mechanisms which lead to dissecting aortic aneu-
rysm in patients with CS remain unclear. A possible expli-
cation may be partially attributed to the excess of cortisol 
secretion with chronic hypercortisolemia which has been 
demonstrated to cause arteriosclerosis, hypertension and dis-
secting aneurysm in investigations of experimental model. 
In fact, some authors have reported that dissecting aortic an-
eurysm is produced in hamsters by cortisone, and cellular 
metaplasic transformation of smooth muscle cells to fibro-
blast-like cells has been observed in the media of the aorta 
adjacent to aneurysm [12, 13].
 One other important factor which should be taken into 
account is the duration of the disease. In patients with CS 
there is a positive correlation between duration exposed to 
the hypercortisolism and the severity of hypertension, which 
is the most important risk factor for aortic dissection [14].
 In conclusion, we presented the third case of patient 
with Stanford type B aortic dissection and CS caused by ad-
renocortical adenoma.
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